272 related articles for article (PubMed ID: 11304678)
1. Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells.
Hyder SM; Chiappetta C; Stancel GM
Int J Cancer; 2001 May; 92(4):469-73. PubMed ID: 11304678
[TBL] [Abstract][Full Text] [Related]
2. Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Hyder SM; Murthy L; Stancel GM
Cancer Res; 1998 Feb; 58(3):392-5. PubMed ID: 9458078
[TBL] [Abstract][Full Text] [Related]
3. Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells.
Wu J; Brandt S; Hyder SM
Mol Endocrinol; 2005 Feb; 19(2):312-26. PubMed ID: 15528272
[TBL] [Abstract][Full Text] [Related]
4. Regulation of vascular endothelial growth factor expression by estrogens and progestins.
Hyder SM; Huang JC; Nawaz Z; Boettger-Tong H; Mäkelä S; Chiappetta C; Stancel GM
Environ Health Perspect; 2000 Oct; 108 Suppl 5():785-90. PubMed ID: 11035983
[TBL] [Abstract][Full Text] [Related]
5. Induction of the angiogenic factor VEGF in the uterus by the antiprogestin onapristone.
Hyder SM; Chiappetta C; Stancel GM
Cancer Lett; 2000 Aug; 156(1):101-7. PubMed ID: 10840165
[TBL] [Abstract][Full Text] [Related]
6. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.
Wu J; Richer J; Horwitz KB; Hyder SM
Cancer Res; 2004 Mar; 64(6):2238-44. PubMed ID: 15026368
[TBL] [Abstract][Full Text] [Related]
7. Proliferation of endothelial and tumor epithelial cells by progestin-induced vascular endothelial growth factor from human breast cancer cells: paracrine and autocrine effects.
Liang Y; Hyder SM
Endocrinology; 2005 Aug; 146(8):3632-41. PubMed ID: 15845615
[TBL] [Abstract][Full Text] [Related]
8. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor in primate endometrium is regulated by oestrogen-receptor and progesterone-receptor ligands in vivo.
Greb RR; Heikinheimo O; Williams RF; Hodgen GD; Goodman AL
Hum Reprod; 1997 Jun; 12(6):1280-92. PubMed ID: 9222018
[TBL] [Abstract][Full Text] [Related]
10. The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development.
Carroll CE; Liang Y; Benakanakere I; Besch-Williford C; Hyder SM
Int J Oncol; 2013 Jan; 42(1):179-87. PubMed ID: 23123638
[TBL] [Abstract][Full Text] [Related]
11. Progestins suppress estrogen-induced expression of vascular endothelial growth factor (VEGF) subtypes in uterine endometrial cancer cells.
Fujimoto J; Sakaguchi H; Hirose R; Ichigo S; Tamaya T
Cancer Lett; 1999 Jul; 141(1-2):63-71. PubMed ID: 10454244
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells.
Ruohola JK; Valve EM; Karkkainen MJ; Joukov V; Alitalo K; Härkönen PL
Mol Cell Endocrinol; 1999 Mar; 149(1-2):29-40. PubMed ID: 10375015
[TBL] [Abstract][Full Text] [Related]
13. Regulation of vascular endothelial growth factor expression by insulin-like growth factor-I in endometrial adenocarcinoma cells.
Bermont L; Lamielle F; Fauconnet S; Esumi H; Weisz A; Adessi GL
Int J Cancer; 2000 Jan; 85(1):117-23. PubMed ID: 10585594
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells.
Hu YL; Tee MK; Goetzl EJ; Auersperg N; Mills GB; Ferrara N; Jaffe RB
J Natl Cancer Inst; 2001 May; 93(10):762-8. PubMed ID: 11353786
[TBL] [Abstract][Full Text] [Related]
15. Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics.
Liang Y; Besch-Williford C; Brekken RA; Hyder SM
Cancer Res; 2007 Oct; 67(20):9929-36. PubMed ID: 17942925
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of progesterone-induced VEGF production in human breast cancer cells by the pure antiestrogen ICI 182,780.
Hyder SM; Stancel GM
Cancer Lett; 2002 Jul; 181(1):47-53. PubMed ID: 12430178
[TBL] [Abstract][Full Text] [Related]
17. Regulation of progesterone receptor messenger ribonucleic acid by progestin in human endometrial stromal cells.
Tseng L; Zhu HH
Biol Reprod; 1997 Dec; 57(6):1360-6. PubMed ID: 9408241
[TBL] [Abstract][Full Text] [Related]
18. Effects of 17beta-estradiol, progesterone, synthetic progestins, tibolone, and raloxifene on vascular endothelial growth factor and Thrombospondin-1 messenger RNA in breast cancer cells.
Mirkin S; Wong BC; Archer DF
Int J Gynecol Cancer; 2006; 16 Suppl 2():560-3. PubMed ID: 17010073
[TBL] [Abstract][Full Text] [Related]
19. Progestins, progesterone receptor modulators, and progesterone antagonists change VEGF release of endometrial cells in culture.
Classen-Linke I; Alfer J; Krusche CA; Chwalisz K; Rath W; Beier HM
Steroids; 2000; 65(10-11):763-71. PubMed ID: 11108887
[TBL] [Abstract][Full Text] [Related]
20. The anti-progestin RU486 stabilizes the progestin-induced fatty acid synthetase mRNA but does not stimulate its transcription.
Chalbos D; Galtier F; Emiliani S; Rochefort H
J Biol Chem; 1991 May; 266(13):8220-4. PubMed ID: 2022639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
